Managing Lung Cancer Patients Through the COVID-19 Crisis: What to Know

Article

Join oncologists nationwide who have learned from the top leaders in the lung cancer field as they share their insights on coronavirus disease 2019 and how the pandemic is poised to have a significant impact on lung cancer treatment and the health care system. Join us Thursday, May 28, 2020 at 8 PM EST.

Date/Time: Thursday, May 28, 2020 at 8 PM EST

Join oncologists nationwide who have learned from the top leaders in the lung cancer field as they share their insights on coronavirus disease 2019 (COVID-19) and how the pandemic is poised to have a significant impact on lung cancer treatment and the health care system.

Led by Nathan A. Pennell, MD, PhD; Stephen Liu, MD; H. Jack West, MD; Charu Aggarwal, MD, MPH, this webinar will cover all of the key information on treating your patients with lung cancer, who could be at risk for developing COVID-19.

Click here to register today!

Faculty:
Nathan A. Pennell, MD, PhD, Associate Professor; Director, Lung Cancer Medical Oncology Program, Cleveland Clinic, Cleveland, OH

Stephen Liu, MD, Associate Professor of Medicine; Director, Thoracic Oncology, Georgetown University, Washington, DC

H. Jack West, MD, Associate Clinical Professor in Medical Oncology, Executive Director, Employer Services, City of Hope Comprehensive Cancer Center, Irwindale, CA

Charu Aggarwal, MD, MPH, Leslye M. Heisler Assistant Professor of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA

Related Videos
A panel of 5 experts on lung cancer
A panel of 5 experts on lung cancer
George R. Simon, MD, FACP, FCCP
Ashish Saxena, MD, PhD
Eric Vallieres, MD, FRCSC
Benjamin Levy, MD
Pasi A. Jänne, MD, PhD, discusses an exploratory analysis from the FLAURA2 trial of osimertinib plus chemotherapy in treatment-naive, EGFR-mutant NSCLC.